Global Pentavalent Antimonials Market Growth 2025-2031

December 2025 | 89 pages | ID: G06B9972F12EN
LP Information

Abstracts

The global Pentavalent Antimonials market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pentavalent Antimonials, also called pentavalent antimony compounds, are used to treat patients with leishmaniasis, but they have collateral effects and, in some cases, low cure rate. The compounds currently available for clinical use are: sodium stibogluconate and meglumine antimoniate. Pentavalent antimonials can only be given by injection.

United States market for Pentavalent Antimonials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pentavalent Antimonials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pentavalent Antimonials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pentavalent Antimonials players cover Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pentavalent Antimonials Industry Forecast” looks at past sales and reviews total world Pentavalent Antimonials sales in 2024, providing a comprehensive analysis by region and market sector of projected Pentavalent Antimonials sales for 2025 through 2031. With Pentavalent Antimonials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pentavalent Antimonials industry.

This Insight Report provides a comprehensive analysis of the global Pentavalent Antimonials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pentavalent Antimonials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pentavalent Antimonials market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pentavalent Antimonials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pentavalent Antimonials.

This report presents a comprehensive overview, market shares, and growth opportunities of Pentavalent Antimonials market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Sodium Stibogluconate
• Meglumine Antimoniate

Segmentation by Application:

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi
• GlaxoSmithKline
• Bristol-Myers Squibb
• Maiden Pharmaceuticals
• Xinhua Pharm
• Albert David
• Science Direct

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pentavalent Antimonials market?

What factors are driving Pentavalent Antimonials market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pentavalent Antimonials market opportunities vary by end market size?

How does Pentavalent Antimonials break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pentavalent Antimonials Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Pentavalent Antimonials by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Pentavalent Antimonials by Country/Region, 2020, 2024 & 2031
2.2 Pentavalent Antimonials Segment by Type
  2.2.1 Sodium Stibogluconate
  2.2.2 Meglumine Antimoniate
2.3 Pentavalent Antimonials Sales by Type
  2.3.1 Global Pentavalent Antimonials Sales Market Share by Type (2020-2025)
  2.3.2 Global Pentavalent Antimonials Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Pentavalent Antimonials Sale Price by Type (2020-2025)
2.4 Pentavalent Antimonials Segment by Application
  2.4.1 Hospitals Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Pentavalent Antimonials Sales by Application
  2.5.1 Global Pentavalent Antimonials Sale Market Share by Application (2020-2025)
  2.5.2 Global Pentavalent Antimonials Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Pentavalent Antimonials Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Pentavalent Antimonials Breakdown Data by Company
  3.1.1 Global Pentavalent Antimonials Annual Sales by Company (2020-2025)
  3.1.2 Global Pentavalent Antimonials Sales Market Share by Company (2020-2025)
3.2 Global Pentavalent Antimonials Annual Revenue by Company (2020-2025)
  3.2.1 Global Pentavalent Antimonials Revenue by Company (2020-2025)
  3.2.2 Global Pentavalent Antimonials Revenue Market Share by Company (2020-2025)
3.3 Global Pentavalent Antimonials Sale Price by Company
3.4 Key Manufacturers Pentavalent Antimonials Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pentavalent Antimonials Product Location Distribution
  3.4.2 Players Pentavalent Antimonials Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PENTAVALENT ANTIMONIALS BY GEOGRAPHIC REGION

4.1 World Historic Pentavalent Antimonials Market Size by Geographic Region (2020-2025)
  4.1.1 Global Pentavalent Antimonials Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Pentavalent Antimonials Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pentavalent Antimonials Market Size by Country/Region (2020-2025)
  4.2.1 Global Pentavalent Antimonials Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Pentavalent Antimonials Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pentavalent Antimonials Sales Growth
4.4 APAC Pentavalent Antimonials Sales Growth
4.5 Europe Pentavalent Antimonials Sales Growth
4.6 Middle East & Africa Pentavalent Antimonials Sales Growth

5 AMERICAS

5.1 Americas Pentavalent Antimonials Sales by Country
  5.1.1 Americas Pentavalent Antimonials Sales by Country (2020-2025)
  5.1.2 Americas Pentavalent Antimonials Revenue by Country (2020-2025)
5.2 Americas Pentavalent Antimonials Sales by Type (2020-2025)
5.3 Americas Pentavalent Antimonials Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pentavalent Antimonials Sales by Region
  6.1.1 APAC Pentavalent Antimonials Sales by Region (2020-2025)
  6.1.2 APAC Pentavalent Antimonials Revenue by Region (2020-2025)
6.2 APAC Pentavalent Antimonials Sales by Type (2020-2025)
6.3 APAC Pentavalent Antimonials Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pentavalent Antimonials by Country
  7.1.1 Europe Pentavalent Antimonials Sales by Country (2020-2025)
  7.1.2 Europe Pentavalent Antimonials Revenue by Country (2020-2025)
7.2 Europe Pentavalent Antimonials Sales by Type (2020-2025)
7.3 Europe Pentavalent Antimonials Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pentavalent Antimonials by Country
  8.1.1 Middle East & Africa Pentavalent Antimonials Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Pentavalent Antimonials Revenue by Country (2020-2025)
8.2 Middle East & Africa Pentavalent Antimonials Sales by Type (2020-2025)
8.3 Middle East & Africa Pentavalent Antimonials Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pentavalent Antimonials
10.3 Manufacturing Process Analysis of Pentavalent Antimonials
10.4 Industry Chain Structure of Pentavalent Antimonials

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pentavalent Antimonials Distributors
11.3 Pentavalent Antimonials Customer

12 WORLD FORECAST REVIEW FOR PENTAVALENT ANTIMONIALS BY GEOGRAPHIC REGION

12.1 Global Pentavalent Antimonials Market Size Forecast by Region
  12.1.1 Global Pentavalent Antimonials Forecast by Region (2026-2031)
  12.1.2 Global Pentavalent Antimonials Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pentavalent Antimonials Forecast by Type (2026-2031)
12.7 Global Pentavalent Antimonials Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Pentavalent Antimonials Product Portfolios and Specifications
  13.1.3 Sanofi Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Pentavalent Antimonials Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
13.3 Bristol-Myers Squibb
  13.3.1 Bristol-Myers Squibb Company Information
  13.3.2 Bristol-Myers Squibb Pentavalent Antimonials Product Portfolios and Specifications
  13.3.3 Bristol-Myers Squibb Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Bristol-Myers Squibb Main Business Overview
  13.3.5 Bristol-Myers Squibb Latest Developments
13.4 Maiden Pharmaceuticals
  13.4.1 Maiden Pharmaceuticals Company Information
  13.4.2 Maiden Pharmaceuticals Pentavalent Antimonials Product Portfolios and Specifications
  13.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Maiden Pharmaceuticals Main Business Overview
  13.4.5 Maiden Pharmaceuticals Latest Developments
13.5 Xinhua Pharm
  13.5.1 Xinhua Pharm Company Information
  13.5.2 Xinhua Pharm Pentavalent Antimonials Product Portfolios and Specifications
  13.5.3 Xinhua Pharm Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Xinhua Pharm Main Business Overview
  13.5.5 Xinhua Pharm Latest Developments
13.6 Albert David
  13.6.1 Albert David Company Information
  13.6.2 Albert David Pentavalent Antimonials Product Portfolios and Specifications
  13.6.3 Albert David Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Albert David Main Business Overview
  13.6.5 Albert David Latest Developments
13.7 Science Direct
  13.7.1 Science Direct Company Information
  13.7.2 Science Direct Pentavalent Antimonials Product Portfolios and Specifications
  13.7.3 Science Direct Pentavalent Antimonials Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Science Direct Main Business Overview
  13.7.5 Science Direct Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pentavalent Antimonials Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pentavalent Antimonials Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sodium Stibogluconate
Table 4. Major Players of Meglumine Antimoniate
Table 5. Global Pentavalent Antimonials Sales by Type (2020-2025) & (g)
Table 6. Global Pentavalent Antimonials Sales Market Share by Type (2020-2025)
Table 7. Global Pentavalent Antimonials Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pentavalent Antimonials Revenue Market Share by Type (2020-2025)
Table 9. Global Pentavalent Antimonials Sale Price by Type (2020-2025) & (USD/mg)
Table 10. Global Pentavalent Antimonials Sale by Application (2020-2025) & (g)
Table 11. Global Pentavalent Antimonials Sale Market Share by Application (2020-2025)
Table 12. Global Pentavalent Antimonials Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pentavalent Antimonials Revenue Market Share by Application (2020-2025)
Table 14. Global Pentavalent Antimonials Sale Price by Application (2020-2025) & (USD/mg)
Table 15. Global Pentavalent Antimonials Sales by Company (2020-2025) & (g)
Table 16. Global Pentavalent Antimonials Sales Market Share by Company (2020-2025)
Table 17. Global Pentavalent Antimonials Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pentavalent Antimonials Revenue Market Share by Company (2020-2025)
Table 19. Global Pentavalent Antimonials Sale Price by Company (2020-2025) & (USD/mg)
Table 20. Key Manufacturers Pentavalent Antimonials Producing Area Distribution and Sales Area
Table 21. Players Pentavalent Antimonials Products Offered
Table 22. Pentavalent Antimonials Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pentavalent Antimonials Sales by Geographic Region (2020-2025) & (g)
Table 26. Global Pentavalent Antimonials Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pentavalent Antimonials Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pentavalent Antimonials Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pentavalent Antimonials Sales by Country/Region (2020-2025) & (g)
Table 30. Global Pentavalent Antimonials Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pentavalent Antimonials Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pentavalent Antimonials Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pentavalent Antimonials Sales by Country (2020-2025) & (g)
Table 34. Americas Pentavalent Antimonials Sales Market Share by Country (2020-2025)
Table 35. Americas Pentavalent Antimonials Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pentavalent Antimonials Sales by Type (2020-2025) & (g)
Table 37. Americas Pentavalent Antimonials Sales by Application (2020-2025) & (g)
Table 38. APAC Pentavalent Antimonials Sales by Region (2020-2025) & (g)
Table 39. APAC Pentavalent Antimonials Sales Market Share by Region (2020-2025)
Table 40. APAC Pentavalent Antimonials Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pentavalent Antimonials Sales by Type (2020-2025) & (g)
Table 42. APAC Pentavalent Antimonials Sales by Application (2020-2025) & (g)
Table 43. Europe Pentavalent Antimonials Sales by Country (2020-2025) & (g)
Table 44. Europe Pentavalent Antimonials Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pentavalent Antimonials Sales by Type (2020-2025) & (g)
Table 46. Europe Pentavalent Antimonials Sales by Application (2020-2025) & (g)
Table 47. Middle East & Africa Pentavalent Antimonials Sales by Country (2020-2025) & (g)
Table 48. Middle East & Africa Pentavalent Antimonials Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pentavalent Antimonials Sales by Type (2020-2025) & (g)
Table 50. Middle East & Africa Pentavalent Antimonials Sales by Application (2020-2025) & (g)
Table 51. Key Market Drivers & Growth Opportunities of Pentavalent Antimonials
Table 52. Key Market Challenges & Risks of Pentavalent Antimonials
Table 53. Key Industry Trends of Pentavalent Antimonials
Table 54. Pentavalent Antimonials Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pentavalent Antimonials Distributors List
Table 57. Pentavalent Antimonials Customer List
Table 58. Global Pentavalent Antimonials Sales Forecast by Region (2026-2031) & (g)
Table 59. Global Pentavalent Antimonials Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pentavalent Antimonials Sales Forecast by Country (2026-2031) & (g)
Table 61. Americas Pentavalent Antimonials Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pentavalent Antimonials Sales Forecast by Region (2026-2031) & (g)
Table 63. APAC Pentavalent Antimonials Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pentavalent Antimonials Sales Forecast by Country (2026-2031) & (g)
Table 65. Europe Pentavalent Antimonials Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pentavalent Antimonials Sales Forecast by Country (2026-2031) & (g)
Table 67. Middle East & Africa Pentavalent Antimonials Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pentavalent Antimonials Sales Forecast by Type (2026-2031) & (g)
Table 69. Global Pentavalent Antimonials Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pentavalent Antimonials Sales Forecast by Application (2026-2031) & (g)
Table 71. Global Pentavalent Antimonials Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pentavalent Antimonials Product Portfolios and Specifications
Table 74. Sanofi Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. GlaxoSmithKline Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Pentavalent Antimonials Product Portfolios and Specifications
Table 79. GlaxoSmithKline Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Latest Developments
Table 82. Bristol-Myers Squibb Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 83. Bristol-Myers Squibb Pentavalent Antimonials Product Portfolios and Specifications
Table 84. Bristol-Myers Squibb Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 85. Bristol-Myers Squibb Main Business
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Maiden Pharmaceuticals Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 88. Maiden Pharmaceuticals Pentavalent Antimonials Product Portfolios and Specifications
Table 89. Maiden Pharmaceuticals Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 90. Maiden Pharmaceuticals Main Business
Table 91. Maiden Pharmaceuticals Latest Developments
Table 92. Xinhua Pharm Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 93. Xinhua Pharm Pentavalent Antimonials Product Portfolios and Specifications
Table 94. Xinhua Pharm Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 95. Xinhua Pharm Main Business
Table 96. Xinhua Pharm Latest Developments
Table 97. Albert David Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 98. Albert David Pentavalent Antimonials Product Portfolios and Specifications
Table 99. Albert David Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 100. Albert David Main Business
Table 101. Albert David Latest Developments
Table 102. Science Direct Basic Information, Pentavalent Antimonials Manufacturing Base, Sales Area and Its Competitors
Table 103. Science Direct Pentavalent Antimonials Product Portfolios and Specifications
Table 104. Science Direct Pentavalent Antimonials Sales (g), Revenue ($ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 105. Science Direct Main Business
Table 106. Science Direct Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pentavalent Antimonials
Figure 2. Pentavalent Antimonials Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pentavalent Antimonials Sales Growth Rate 2020-2031 (g)
Figure 7. Global Pentavalent Antimonials Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pentavalent Antimonials Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pentavalent Antimonials Sales Market Share by Country/Region (2024)
Figure 10. Pentavalent Antimonials Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sodium Stibogluconate
Figure 12. Product Picture of Meglumine Antimoniate
Figure 13. Global Pentavalent Antimonials Sales Market Share by Type in 2025
Figure 14. Global Pentavalent Antimonials Revenue Market Share by Type (2020-2025)
Figure 15. Pentavalent Antimonials Consumed in Hospitals Pharmacies
Figure 16. Global Pentavalent Antimonials Market: Hospitals Pharmacies (2020-2025) & (g)
Figure 17. Pentavalent Antimonials Consumed in Retail Pharmacies
Figure 18. Global Pentavalent Antimonials Market: Retail Pharmacies (2020-2025) & (g)
Figure 19. Pentavalent Antimonials Consumed in Online Pharmacies
Figure 20. Global Pentavalent Antimonials Market: Online Pharmacies (2020-2025) & (g)
Figure 21. Global Pentavalent Antimonials Sale Market Share by Application (2024)
Figure 22. Global Pentavalent Antimonials Revenue Market Share by Application in 2025
Figure 23. Pentavalent Antimonials Sales by Company in 2025 (g)
Figure 24. Global Pentavalent Antimonials Sales Market Share by Company in 2025
Figure 25. Pentavalent Antimonials Revenue by Company in 2025 ($ millions)
Figure 26. Global Pentavalent Antimonials Revenue Market Share by Company in 2025
Figure 27. Global Pentavalent Antimonials Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pentavalent Antimonials Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pentavalent Antimonials Sales 2020-2025 (g)
Figure 30. Americas Pentavalent Antimonials Revenue 2020-2025 ($ millions)
Figure 31. APAC Pentavalent Antimonials Sales 2020-2025 (g)
Figure 32. APAC Pentavalent Antimonials Revenue 2020-2025 ($ millions)
Figure 33. Europe Pentavalent Antimonials Sales 2020-2025 (g)
Figure 34. Europe Pentavalent Antimonials Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pentavalent Antimonials Sales 2020-2025 (g)
Figure 36. Middle East & Africa Pentavalent Antimonials Revenue 2020-2025 ($ millions)
Figure 37. Americas Pentavalent Antimonials Sales Market Share by Country in 2025
Figure 38. Americas Pentavalent Antimonials Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pentavalent Antimonials Sales Market Share by Type (2020-2025)
Figure 40. Americas Pentavalent Antimonials Sales Market Share by Application (2020-2025)
Figure 41. United States Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pentavalent Antimonials Sales Market Share by Region in 2025
Figure 46. APAC Pentavalent Antimonials Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pentavalent Antimonials Sales Market Share by Type (2020-2025)
Figure 48. APAC Pentavalent Antimonials Sales Market Share by Application (2020-2025)
Figure 49. China Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pentavalent Antimonials Sales Market Share by Country in 2025
Figure 57. Europe Pentavalent Antimonials Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pentavalent Antimonials Sales Market Share by Type (2020-2025)
Figure 59. Europe Pentavalent Antimonials Sales Market Share by Application (2020-2025)
Figure 60. Germany Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pentavalent Antimonials Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pentavalent Antimonials Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pentavalent Antimonials Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pentavalent Antimonials Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pentavalent Antimonials in 2025
Figure 74. Manufacturing Process Analysis of Pentavalent Antimonials
Figure 75. Industry Chain Structure of Pentavalent Antimonials
Figure 76. Channels of Distribution
Figure 77. Global Pentavalent Antimonials Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pentavalent Antimonials Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pentavalent Antimonials Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pentavalent Antimonials Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pentavalent Antimonials Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pentavalent Antimonials Revenue Market Share Forecast by Application (2026-2031)